Today: 9 June 2026
Browse Category

NYSE:CE 29 September 2025

Why 5G Internet Providers Are Replacing Cable Faster Than You Think

Chemical Giant Celanese Goes All-In on Private 5G – A Game-Changer for Its Factories

Celanese has deployed a fully managed private 5G network from NTT DATA at two Texas plants to improve automation, safety, and real-time data flow. The on-premises system uses Celona radios and NTT DATA’s cloud platform, replacing Wi-Fi for more reliable factory connectivity. The company operates 25 plants worldwide and cites the network as key to eliminating signal gaps and disruptions.
29 September 2025

Stock Market Today

  • Glaukos (GKOS) Shares Show Volatility Amid 19% Undervaluation Claim
    June 9, 2026, 9:42 AM EDT. Glaukos (GKOS) shares rose 18% in the past week but fell nearly 9% over the last month, reflecting short-term volatility. The stock trades at $121.96, below its fair value estimate of $151.08, suggesting a 19.3% undervaluation. The company's focus on ophthalmic therapies, including iDose TR for glaucoma, underpins a potential shift in treatment approaches driven by an aging population and increasing glaucoma cases. Investors consider this a long-term growth opportunity, though realization depends on product adoption and reimbursement policies. Glaukos posted a one-year total shareholder return of 28.87%, indicating sustained momentum despite recent fluctuations. The valuation hinges on expectations of revenue growth, profitability turnaround, and premium earnings multiples typical of high growth firms.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Go toTop